Peter Fontana, MD | |
800 Meadows Rd, Boca Raton, FL 33486-2304 | |
(561) 955-4425 | |
Not Available |
Full Name | Peter Fontana |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Experience | 23 Years |
Location | 800 Meadows Rd, Boca Raton, Florida |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1811060130 | NPI | - | NPPES |
02570818 | Medicaid | NY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 230419 (New York) | Secondary |
207P00000X | Emergency Medicine | ME112731 (Florida) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Boca Raton Regional Hospital | Boca raton, FL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Emed Llp | 1557259975 | 7 |
News Archive
Before sharing human research data, scientists routinely strip it of personal information such as name, address, and birthdate in order to protect the privacy of their study participants.
Wellington Foods, Inc., a leading nutritional supplement manufacturer, has announced the expansion of its production operation to its new headquarters in Corona, California. Moving to the larger state-of-the-art manufacturing facility, Wellington Foods has made a significant commitment to the long-term growth of the company and to the natural products industry.
Ancon Technologies, a company devoted to finding new ways to beat cancer, recently unveiled a new cancer-screening device to the public, the NBT detector. The company's latest product aims to bring cancer detection to the next level: it uses Nanoparticle Biomarker Tagging technology to identify cancer biomarkers in exhaled air.
Bardet-Biedl syndrome (BBS), characterized by obesity, learning disabilities and eye and kidney problems, is caused by genetic mutations in the BBS family of genes. Now, researchers who've long studied the condition have discovered that genetic mutations in one of those genes, called BBS4, lead to cell death by disrupting the cells' internal "highway" system.
Octapharma AG, one of the largest human protein products manufacturers in the world, and Octapharma USA today announced that patients diagnosed with severe hemophilia A have started treatment in a multi-center study that is researching the use of the first recombinant Factor VIII (rFVIII) derived from a human cell line (Human-cl rhFVIII).
› Verified 2 days ago
Entity Name | Emed Llp |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1043206212 PECOS PAC ID: 1557259975 Enrollment ID: O20040308000995 |
News Archive
Before sharing human research data, scientists routinely strip it of personal information such as name, address, and birthdate in order to protect the privacy of their study participants.
Wellington Foods, Inc., a leading nutritional supplement manufacturer, has announced the expansion of its production operation to its new headquarters in Corona, California. Moving to the larger state-of-the-art manufacturing facility, Wellington Foods has made a significant commitment to the long-term growth of the company and to the natural products industry.
Ancon Technologies, a company devoted to finding new ways to beat cancer, recently unveiled a new cancer-screening device to the public, the NBT detector. The company's latest product aims to bring cancer detection to the next level: it uses Nanoparticle Biomarker Tagging technology to identify cancer biomarkers in exhaled air.
Bardet-Biedl syndrome (BBS), characterized by obesity, learning disabilities and eye and kidney problems, is caused by genetic mutations in the BBS family of genes. Now, researchers who've long studied the condition have discovered that genetic mutations in one of those genes, called BBS4, lead to cell death by disrupting the cells' internal "highway" system.
Octapharma AG, one of the largest human protein products manufacturers in the world, and Octapharma USA today announced that patients diagnosed with severe hemophilia A have started treatment in a multi-center study that is researching the use of the first recombinant Factor VIII (rFVIII) derived from a human cell line (Human-cl rhFVIII).
› Verified 2 days ago
Entity Name | Phoenix Emergency Medicine Of Broward Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1871542969 PECOS PAC ID: 5991793002 Enrollment ID: O20040505001132 |
News Archive
Before sharing human research data, scientists routinely strip it of personal information such as name, address, and birthdate in order to protect the privacy of their study participants.
Wellington Foods, Inc., a leading nutritional supplement manufacturer, has announced the expansion of its production operation to its new headquarters in Corona, California. Moving to the larger state-of-the-art manufacturing facility, Wellington Foods has made a significant commitment to the long-term growth of the company and to the natural products industry.
Ancon Technologies, a company devoted to finding new ways to beat cancer, recently unveiled a new cancer-screening device to the public, the NBT detector. The company's latest product aims to bring cancer detection to the next level: it uses Nanoparticle Biomarker Tagging technology to identify cancer biomarkers in exhaled air.
Bardet-Biedl syndrome (BBS), characterized by obesity, learning disabilities and eye and kidney problems, is caused by genetic mutations in the BBS family of genes. Now, researchers who've long studied the condition have discovered that genetic mutations in one of those genes, called BBS4, lead to cell death by disrupting the cells' internal "highway" system.
Octapharma AG, one of the largest human protein products manufacturers in the world, and Octapharma USA today announced that patients diagnosed with severe hemophilia A have started treatment in a multi-center study that is researching the use of the first recombinant Factor VIII (rFVIII) derived from a human cell line (Human-cl rhFVIII).
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Peter Fontana, MD 16881 Pierre Cir, Delray Beach, FL 33446-3692 Ph: () - | Peter Fontana, MD 800 Meadows Rd, Boca Raton, FL 33486-2304 Ph: (561) 955-4425 |
News Archive
Before sharing human research data, scientists routinely strip it of personal information such as name, address, and birthdate in order to protect the privacy of their study participants.
Wellington Foods, Inc., a leading nutritional supplement manufacturer, has announced the expansion of its production operation to its new headquarters in Corona, California. Moving to the larger state-of-the-art manufacturing facility, Wellington Foods has made a significant commitment to the long-term growth of the company and to the natural products industry.
Ancon Technologies, a company devoted to finding new ways to beat cancer, recently unveiled a new cancer-screening device to the public, the NBT detector. The company's latest product aims to bring cancer detection to the next level: it uses Nanoparticle Biomarker Tagging technology to identify cancer biomarkers in exhaled air.
Bardet-Biedl syndrome (BBS), characterized by obesity, learning disabilities and eye and kidney problems, is caused by genetic mutations in the BBS family of genes. Now, researchers who've long studied the condition have discovered that genetic mutations in one of those genes, called BBS4, lead to cell death by disrupting the cells' internal "highway" system.
Octapharma AG, one of the largest human protein products manufacturers in the world, and Octapharma USA today announced that patients diagnosed with severe hemophilia A have started treatment in a multi-center study that is researching the use of the first recombinant Factor VIII (rFVIII) derived from a human cell line (Human-cl rhFVIII).
› Verified 2 days ago
Dr. Michael Andrew Coplin, M.D., M.B.A Emergency Medicine Medicare: Medicare Enrolled Practice Location: 800 Meadows Rd, Boca Raton, FL 33486 Phone: 561-955-7100 | |
Jamie A Alvarez, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 Meadows Rd, Boca Raton, FL 33486 Phone: 561-395-7100 | |
Dr. Jeffrey Ingeman, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 21644 Sr 7, Er Department, Boca Raton, FL 33428 Phone: 561-488-8200 Fax: 561-488-8374 | |
Adam B Bernstein, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 800 Meadows Rd, Boca Raton, FL 33486 Phone: 561-395-7100 | |
Sara S. Levine, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 7035 Beracasa Way, Suite 102, Boca Raton, FL 33433 Phone: 561-750-2338 Fax: 561-750-2313 | |
Dr. Deborah M Lieberman, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 21644 State Road 7, Emergency Department, Boca Raton, FL 33428 Phone: 561-488-8000 Fax: 904-346-0113 | |
David A Leeman, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 800 Meadows Rd, Boca Raton, FL 33486 Phone: 561-395-7100 |